Literature DB >> 28671119

Four Decades of Research in Alzheimer's Disease (1975-2014): A Bibliometric and Scientometric Analysis.

Alberto Serrano-Pozo1, Georgina M Aldridge1, Qiang Zhang1.   

Abstract

BACKGROUND: Bibliometric and scientometric methods can be applied to the study of a research field.
OBJECTIVE: We hypothesized that a bibliometric and scientometric analysis of the Alzheimer's disease (AD) research field could render trends that provide researchers and funding agencies valuable insight into the history of the field, current tendencies, and potential future directions.
METHODS: We performed searches in publicly available databases including PubMed, Scopus, Web of Science, and Alzheimer's Funding Analyzer for the period 1975-2014, and conducted a curve fitting analysis with non-linear regression.
RESULTS: While the rate and impact of publications continue to increase, the number of patents per year is currently declining after peaking in the late 2000s, and the funding budget has plateaued in the last 5-10 years analyzed. Genetics is the area growing at a fastest pace, whereas pathophysiology and therapy have not grown further in the last decade. Among the targets of pathophysiology research, amyloid-β continues to be the focus of greatest interest, with tau and apolipoprotein E stagnant after a surge in the 1990s. The role of inflammation, microglia, and the synapse are other research topics with growing interest. Regarding preventative strategies, education attainment, diet, and exercise are recently gaining some momentum, whereas NSAIDs and statins have lost the spotlight they once had.
CONCLUSION: Our bibliometric and scientometric analysis provides distinct trends in AD research in the last four decades, including publication and patent output, funding, impact, and topics. Our findings could inform the decision-making of research funding agencies in the near future.

Entities:  

Keywords:  Alzheimer’s disease; amyloid-β peptides; bibliometrics; h-index; neurofibrillary tangle; scientometrics; tau proteins

Mesh:

Year:  2017        PMID: 28671119      PMCID: PMC6002842          DOI: 10.3233/JAD-170184

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  94 in total

1.  A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease.

Authors:  H Feldman; S Gauthier; J Hecker; B Vellas; P Subbiah; E Whalen
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

2.  Editorial: The prevalence and malignancy of Alzheimer disease. A major killer.

Authors:  R Katzman
Journal:  Arch Neurol       Date:  1976-04

3.  Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib.

Authors:  Barbara K Martin; Christine Szekely; Jason Brandt; Steven Piantadosi; John C S Breitner; Suzanne Craft; Denis Evans; Robert Green; Michael Mullan
Journal:  Arch Neurol       Date:  2008-05-12

4.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

5.  A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

Authors:  P N Tariot; P R Solomon; J C Morris; P Kershaw; S Lilienfeld; C Ding
Journal:  Neurology       Date:  2000-06-27       Impact factor: 9.910

6.  Statins and the risk of dementia.

Authors:  H Jick; G L Zornberg; S S Jick; S Seshadri; D A Drachman
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

Review 7.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

8.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.

Authors:  D Games; D Adams; R Alessandrini; R Barbour; P Berthelette; C Blackwell; T Carr; J Clemens; T Donaldson; F Gillespie
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

9.  Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe Consortium.

Authors:  Irina Alafuzoff; Maria Pikkarainen; Safa Al-Sarraj; Thomas Arzberger; Jeanne Bell; Istvan Bodi; Nenad Bogdanovic; Herbert Budka; Orso Bugiani; Isidro Ferrer; Ellen Gelpi; Giorgio Giaccone; Manuel B Graeber; Jean-Jacques Hauw; Wouter Kamphorst; Andrew King; Nicolas Kopp; Penelope Korkolopoulou; Gábor G Kovács; David Meyronet; Piero Parchi; Efstratios Patsouris; Matthias Preusser; Rivka Ravid; Wolfgang Roggendorf; Danielle Seilhean; Nathalie Streichenberger; Dietmar R Thal; Hans Kretzschmar
Journal:  J Neuropathol Exp Neurol       Date:  2006-08       Impact factor: 3.685

10.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

View more
  9 in total

Review 1.  Is Alzheimer's Disease Risk Modifiable?

Authors:  Alberto Serrano-Pozo; John H Growdon
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 2.  Contribution of Iranian researchers in Alzheimer's disease research: A 10 years scientometric analysis.

Authors:  Arash Ghazbani; Mohammad Javad Mansourzadeh; Golbarg Mehdizadeh; Mojtaba Ghobadi; Seyed Masoud Arzaghi; Afshin Ostovar
Journal:  J Diabetes Metab Disord       Date:  2021-11-04

3.  CogTale: an online platform for the evaluation, synthesis, and dissemination of evidence from cognitive interventions studies.

Authors:  Julieta Sabates; Sylvie Belleville; Mary Castellani; Tzvi Dwolatzky; Benjamin M Hampstead; Amit Lampit; Sharon Simon; Kaarin Anstey; Belinda Goodenough; Serafino Mancuso; Davis Marques; Richard Sinnott; Alex Bahar-Fuchs
Journal:  Syst Rev       Date:  2021-08-24

4.  Editorial: The Role of Glia in Alzheimer's Disease.

Authors:  Beatriz G Pérez-Nievas; Alberto Serrano-Pozo
Journal:  Front Neurol       Date:  2019-01-11       Impact factor: 4.003

5.  Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer's disease brains.

Authors:  Yaxing Gui; Jordan D Marks; Sudeshna Das; Bradley T Hyman; Alberto Serrano-Pozo
Journal:  Brain Pathol       Date:  2019-07-25       Impact factor: 6.508

6.  Thematic research clusters in very old populations (≥ 80 years): a bibliometric approach.

Authors:  Gregorio Gonzalez-Alcaide; Sergio Palacios-Fernandez; Jose-Manuel Ramos-Rincon
Journal:  BMC Geriatr       Date:  2021-04-21       Impact factor: 3.921

7.  A Bibliometric Review on Gut Microbiome and Alzheimer's Disease Between 2012 and 2021.

Authors:  Alejandro I Trejo-Castro; Diego Carrion-Alvarez; Antonio Martinez-Torteya; Claudia Rangel-Escareño
Journal:  Front Aging Neurosci       Date:  2022-07-11       Impact factor: 5.702

8.  Sex and APOE Genotype Alter the Basal and Induced Inflammatory States of Primary Microglia from APOE Targeted Replacement Mice.

Authors:  Isha Mhatre-Winters; Aseel Eid; Yoonhee Han; Kim Tieu; Jason R Richardson
Journal:  Int J Mol Sci       Date:  2022-08-29       Impact factor: 6.208

9.  A Bibliometric and Visual Analysis of Exercise Intervention Publications for Alzheimer's Disease (1998-2021).

Authors:  Xiao-Wei Feng; Maryam Hadizadeh; Lin-Hong Zheng; Wei-Han Li
Journal:  J Clin Med       Date:  2022-10-06       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.